{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:06:15Z","timestamp":1743307575559,"version":"3.40.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T00:00:00Z","timestamp":1338940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s13730-012-0018-1","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T17:42:33Z","timestamp":1338918153000},"page":"82-85","source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment with tolvaptan to control blood volume and hyponatremia in a chronic kidney disease patient"],"prefix":"10.1007","volume":"1","author":[{"given":"Tomoyuki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wako","family":"Yumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,6]]},"reference":[{"issue":"6","key":"18_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(96)90380-7","volume":"28","author":"VM Buckalew Jr","year":"1996","unstructured":"Buckalew VM Jr, Berg RL, Wang SR, Porush JG, Rauch S, Schulman G. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis. 1996;28(6):811\u201321.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"18_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200201000-00002","volume":"20","author":"RA Augustyniak","year":"2002","unstructured":"Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens. 2002;20(1):3\u20139.","journal-title":"J Hypertens"},{"issue":"6","key":"18_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","volume":"44","author":"JM McCurley","year":"2004","unstructured":"McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M, Haigney MC. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol. 2004;44(6):1301\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"18_CR4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","volume":"355","author":"RW Schrier","year":"2006","unstructured":"Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099\u2013112.","journal-title":"N Engl J Med"},{"issue":"12","key":"18_CR5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297(12):1319\u201331.","journal-title":"JAMA"},{"issue":"2 Suppl 1","key":"18_CR6","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1\u2013266.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"18_CR7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.ki.5000284","volume":"69","author":"F Irie","year":"2006","unstructured":"Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69(7):1264\u201371.","journal-title":"Kidney Int"},{"issue":"7","key":"18_CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.166.7.781","volume":"166","author":"A Goldberg","year":"2006","unstructured":"Goldberg A, Hammerman H, Petcherski S, Nassar M, Zdorovyak A, Yalonetsky S, et al. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med. 2006;166(7):781\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"18_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5414\/CNP65028","volume":"65","author":"CC Wu","year":"2006","unstructured":"Wu CC, Yeung LK, Tsai WS, Tseng CF, Chu P, Huang TY, et al. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol. 2006;65(1):28\u201333.","journal-title":"Clin Nephrol"},{"issue":"4","key":"18_CR10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","volume":"130","author":"MC Londo\u00f1o","year":"2006","unstructured":"Londo\u00f1o MC, Guevara M, Rimola A, Navasa M, Taur\u00e0 P, Mas A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130(4):1135\u201343.","journal-title":"Gastroenterology"},{"issue":"9","key":"18_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","volume":"122","author":"SS Waikar","year":"2009","unstructured":"Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122(9):857\u201365.","journal-title":"Am J Med"},{"issue":"10","key":"18_CR12","first-page":"1305","volume":"96","author":"KM Chow","year":"2004","unstructured":"Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc. 2004;96(10):1305\u20138.","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"18_CR13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","volume":"287","author":"Y Yamamura","year":"1998","unstructured":"Yamamura Y, Nakamura S, Itoh S, Hirano T, Onogawa T, Yamashita T, et al. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther. 1998;287(3):860\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"18_CR14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.V113556","volume":"11","author":"LM Moist","year":"2000","unstructured":"Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"18_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","volume":"21","author":"T Berl","year":"2010","unstructured":"Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010;21(4):705\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"18_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.2011.119","volume":"80","author":"MV Irazabal","year":"2011","unstructured":"Irazabal MV, Torres VE, Hogan MC, Glockner J, King BF, Ofstie TG, et al. Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2011;80(3):295\u2013301.","journal-title":"Kidney Int"},{"issue":"10","key":"18_CR17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","volume":"6","author":"E Higashihara","year":"2011","unstructured":"Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, et al. Tolvaptan in autosomal dominant polycystic kidney disease: three years\u2019 experience. Clin J Am Soc Nephrol. 2011;6(10):2499\u2013507.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0018-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-012-0018-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-012-0018-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T10:23:32Z","timestamp":1743243812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-012-0018-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s13730-012-0018-1","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2012,6,6]]}}}